Literature DB >> 11969377

Pathways of proximal tubular cell death in bismuth nephrotoxicity.

Berend T Leussink1, J Fred Nagelkerke, Bob van de Water, Anja Slikkerveer, Gijsbert B van der Voet, Anu Srinivasan, Jan A Bruijn, Frederik A de Wolff, Emile de Heer.   

Abstract

Colloidal bismuth subcitrate (CBS), a drug for treatment of peptic ulcers, has been reported in the literature to be nephrotoxic in humans when taken in high overdoses. To investigate the mechanism of bismuth nephropathy, we developed an animal model by feeding rats single doses of CBS containing 3.0 mmol Bi/kg body weight. Terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling assay, immunostaining for active caspase-3, and electron microscopy showed that proximal tubular epithelial cells die by necrosis and not by apoptosis within 3 h after CBS administration. Exposure of the renal epithelial cell lines NRK-52E and LLC-PK1 to Bi(3+) in citrate buffer served as an in vitro model of bismuth nephropathy. NRK-52E cells exposed to 100 microM Bi(3+) or more died by necrosis, as was demonstrated by nuclear staining with Hoechst 33258 and flow cytometry using Alexa(488)-labeled Annexin-V and the vital nuclear dye TOPRO-3. Bismuth-induced cell death of NRK-52E cells was not prevented by the caspase-3 inhibitor z-VAD-fmk, whereas this inhibitor did prevent cisplatinum-induced apoptosis. Mitochondrial dysfunction and induction of free radicals were shown not to be involved in bismuth nephrotoxicity. The early time point of damage induction in vitro as well as in vivo and the early displacement of N-cadherin, as found in previous studies, suggest that bismuth induces cell death by destabilizing the cell membrane. In conclusion, we showed that high overdose of bismuth induced cell death by necrosis in vivo as well as in vitro, possibly by destabilization of the cell membrane. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11969377     DOI: 10.1006/taap.2002.9379

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Treatment of diarrheal disease.

Authors: 
Journal:  Paediatr Child Health       Date:  2003-09       Impact factor: 2.253

Review 2.  Acute renal failure after overdose of colloidal bismuth subcitrate.

Authors:  Nurcan Cengiz; Yasemin Uslu; Faysal Gök; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

3.  Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model.

Authors:  Robin I J Merkx; Mark Rijpkema; Gerben M Franssen; Annemarie Kip; Bart Smeets; Alfred Morgenstern; Frank Bruchertseifer; Eddie Yan; Michael P Wheatcroft; Egbert Oosterwijk; Peter F A Mulders; Sandra Heskamp
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-02

4.  Cytotoxicity of biologically synthesised bismuth nanoparticles against HT-29 cell line.

Authors:  Mojtaba Shakibaie; Hamid Forootanfar; Atefeh Ameri; Mahboubeh Adeli-Sardou; Mandana Jafari; Hamid Reza Rahimi
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

5.  Bismuth Reduces Cisplatin-Induced Nephrotoxicity Via Enhancing Glutathione Conjugation and Vesicular Transport.

Authors:  Hui Jiang; Yifan Hong; Guorong Fan
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.